Sinovac Provides Update On Study Of Third Dose Of Its Pandemic Influenza Vaccine

Wed, 07 Mar 2007 02:00 PM EST

... Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced an update for the study evaluating the third dose of its vaccine against the H5N1 dose of pandemic influenza. [click link for full article] ...